Buy Adequan i.m – Adequan Equine Dosage
Adequan i.m
- Active Ingredient: Polysulfated glycosaminoglycan (PSGAG)
- Strength: 500 mg/5 ml solution
- Formulation: Sterile injectable solution for intramuscular use
- Target Species: Horses
- Manufacturer: American Regent, Inc.
How It Works
- PSGAG is chemically similar to natural glycosaminoglycans found in articular cartilage.
- It acts as a potent proteolytic enzyme inhibitor, helping to diminish or reverse the breakdown of cartilage matrix.
- Supports joint lubrication, cartilage repair, and reduction of inflammation, improving mobility and reducing lameness.
Key Benefits
- Joint Protection: Slows cartilage degradation and supports regeneration.
- Pain & Lameness Relief: Improves comfort and mobility in horses with degenerative joint disease.
- FDA‑Approved: Only PSGAG equine joint prescription approved in the U.S.
- Trusted by Veterinarians: Widely used in performance and companion horses.
Usage & Administration
- Route: Intramuscular injection.
- Typical Regimen: 500 mg (5 ml) every 4 days for 28 days (7 injections total).
- Veterinary Supervision Required: Must be prescribed and administered by a licensed veterinarian.
- Restrictions: Not for septic arthritis; contraindicated within 24 hours of surgery or in animals with bleeding tendencies.
Risks & Considerations
- Side Effects: Possible injection site reactions, mild bleeding tendencies.
- Contraindications: Do not use in septic arthritis or immediately post‑surgery.
- No Generic Available: Adequan i.m. is the only approved PSGAG product; supplements are not equivalent.
Comparison Table
| Feature | Adequan i.m. | Oral Joint Supplements | NSAIDs (e.g., phenylbutazone) |
|---|---|---|---|
| Active Ingredient | PSGAG (500 mg/5 ml) | Glucosamine, chondroitin | Anti‑inflammatory drugs |
| Mechanism | Cartilage repair, enzyme inhibition | Nutritional support | Pain relief, inflammation reduction |
| Onset of Action | Weeks (structural repair) | Slow, variable | Fast (hours) |
| FDA Approval | Yes | No | Yes |
| Best Use | Degenerative joint disease | Maintenance support | Acute pain management |
Adequan i.m. is a trusted, FDA‑approved injectable therapy for horses suffering from degenerative joint disease. By protecting cartilage, reducing inflammation, and improving mobility, it remains a cornerstone of equine joint health management.
Order today from Vet Ranch Supply to ensure your horses receive professional‑grade joint protection and recovery support.
How adequan i.m Works
adequan i.m Canine polysulfated glycosaminoglycan is administered two times a week for four weeks. The drug is injected intramuscularly to ensure it reaches the critical parts of the joint. It goes to work in the joint in about two hours and stays in the joint for about three days.With Adequan Canine you should see signs of improvement within four weeks. Your dog may begin to act like the playful, active dog you remember.adequan i.m
Cautions:
adequan i.m Canine polysulfated glycosaminoglycan or PSGAG should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Possible side effects pain at injection site, diarrhea and abnormal bleeding were mild, transient and self-limiting. Safety studies of PSGAG in breeding, pregnant or lactating dogs have not been conducted.
Storage Conditions:
Store at controlled room temperature up to 25°C (77°F) (See USP).
Frequently Asked Questions:
Q: What are the signs of canine arthritis?
It is important to note that arthritis occurs before clinical signs are shown. The beginning stages of this disease are not easily recognized. If your dog is suffering from arthritis, you will most likely see one or more of the following signs: lagging behind on walks, reluctance to walking, running, climbing stairs, jumping or playing. Additional signs may include: sluggishness, tiredness, low activity, reluctance to extend rear legs, aggressive or withdrawn behavior or other personality/behavioral changes.
Q: How do I know if my dog is at risk for this disease?
Canine arthritis does not discriminate. This disease can affect all breeds of dogs, but there are certain risk factors that you should be aware of, including: overweight, high activity levels for long periods of time, breed inherited traits, such as hip dysplasia, joint trauma, large breed and over the age of five.
Q: How does Adequan Canine polysulfated glycosaminoglycan or PSGAG work?
Reviews
There are no reviews yet.